Under general anesthesia using a stereotactic brain surgery system, human iPSC-derived dopaminergic progenitors will be transplanted into the bilateral putamen. For the first 3 patients, approximately

2 trials

Sponsors

Kyoto University Hospital

Conditions

Parkinson&#39

Phase 1

Kyoto Trial to Evaluate the Safety and Efficacy of iPSC-derived dopaminergic progenitors in the treatment of Parkinson's Disease

Active, not recruitingJPRN-UMIN000033564

Kyoto University HospitalParkinson&#39

Start: 2018-09-25Target: 7Updated: 2026-06-29

Phase 3

Kyoto Trial to Evaluate the Safety and Efficacy of Tacrolimus in the iPSC-based Therapy for Parkinson's Disease

Active, not recruitingJPRN-UMIN000033565

Kyoto University HospitalParkinson&#39

Start: 2018-09-25Target: 7Updated: 2026-06-29

Related Papers

Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson’s disease

Nature2025-04-1679 citations